THE FORA

THE FORA

Брендтер

141 brands

Өнімдерге оралу

NEXCELL

NEXCELL REVIVE

Қаптама құрамы: 2.5 mL × 3 syringes / box

$120.00 USD

Enquire about this product

Price excludes shipping. Availability and supply conditions are confirmed individually.

PN + RH collagen I & III

A collagen-and-PN formulation with hyaluronic acid, succinic acid and peptides, presented for hydration, texture and firmness.

REVIVE combines PN, recombinant human collagen I and III, succinic acid, peptides and hyaluronic acid. Its product focus is skin quality: moisture, radiance, elasticity and the appearance of fine lines.

The pack contains three 2.5 mL syringes.

Өндіруші
NEXCELL
Өнімдер
REVIVE
Highlighted ingredients
PN · RH collagen I & III · succinic acid · peptides · HA
Қаптама көлемі
2.5 mL × 3 syringes
Storage
1–30°C; protect from light

Nexcell Revive

RH Collagen Types I + III, PN, Peptides, Succinic Acid and HA

Illustration comparing collagen-depleted and collagen-supported skin layers

Ingredient highlights

Formulation overview
Ingredient groupProduct focus
Recombinant human collagen I+IIIDermal matrix and skin-structure concept
PN (polynucleotides)Skin repair and renewal rationale
Hyaluronic acidHydration and moisture retention
PeptidesSkin-renewal signalling rationale
Succinic acidSupports skin renewal and helps improve the appearance of dull, uneven-looking skin.

A focus on skin quality

The product is positioned for dryness, dullness, fine lines and reduced firmness or elasticity.

Face and neck illustration with forehead, frown-line, whole-face and neck labels

Concerns & areas described

REVIVE is designed to support moisture, radiance, smoother-looking texture and the appearance of firmer, denser skin. Its skin-quality focus includes the face, neck, décolletage, upper chest, hands and knees.

Suitability and permitted use must be assessed against the current product label for the destination market.

Four rows of REVIVE histology images labelled Day 1 and Day 10

A variable 6–12-month duration is stated in the available product information, but no supporting clinical study or guaranteed duration is provided. Current product labelling and individual clinical assessment take priority.

The supplied materials do not establish market-specific authorisation. Request current composition, labelling, contraindications and safety information before professional selection.

NEXCELL REVIVE documentation

Request the current full composition, product labelling and market availability.

Бізбен байланысу
NEXCELL REVIVE